
Personalised medicine to relieve the health service
Smaller patient groups and targeted treatments are the future of cancer care in Norway.
A Norwegian perspective: The foundations of the ECHoS project are laid and Cancer Mission activities are speeding up in Norway.
ECHoS is a European project, funded by Horizon Europe Programme. It aims at supporting the implementation of the Cancer Mission activities in all Member State and Associated Country (MS/AC) through the establishment and development of National Cancer Mission Hubs (NCMHs) operating at national, regional, and local levels.
Nov 20, 2023
Sofia Linden
Over the initial six months of ECHoS, Oslo Cancer Cluster and its collaborators have made significant contributions towards achieving the project’s goals by increasing awareness and mobilising the Norwegian ecosystem for the EU’s Mission on Cancer.
With its early setup of the National Cancer Mission Hub in 2021, Norway is well-positioned to implement the Cancer Mission. Partners of the national hub are taking part in the European effort to establish similar structures in all member states and associated countries, under the ECHoS project.
“ECHoS provides an opportunity to explore new collaborative formats among stakeholders, including patients and citizens. It paves the way to establish novel partnerships across sectors and create opportunities to foster innovation in cancer care.” Marine Jeanmougin, Lead EU affairs and digital innovation in Oslo Cancer Cluster
Two public meetings were organised with politicians, experts, and representatives from different sectors in April and August. The debate revolved around the importance to commit to the Mission, how to use Missions as a tool for political change and how Norway can deliver on the Mission.
During The Economist’s World Cancer Series in Brussels, Ketil Widerberg, general manager of Oslo Cancer Cluster, moderated a panel discussion on cancer prevention. Clinicians, policymakers, and patient advocates discussed: How can equal access to screening be guaranteed? And what strategies can be implemented to adopt innovative methods for cancer detection?
Oslo Cancer Cluster recently conducted a working session on multistakeholder cooperation. Discussions addressed the possible challenges in establishing complex partnerships but also the opportunities offered by the mission approach to bring concrete solutions to cancer patients. The event fostered bottom-up thinking among ECHoS partners and tapped into the experience that participants have accumulated within their own ecosystems.
Funded by the European Union under the Horizon Europe Framework Programme. Grant Agreement Nº: 101104587.
Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the European Health and Digital Executive Agency (HaDEA). Neither the European Union nor the granting authority can be held responsible for them.
Smaller patient groups and targeted treatments are the future of cancer care in Norway.
Geir Hetland, Chief Financial Officer of Thermo Fisher Scientific, is the latest addition to the board of Oslo Cancer Cluster.